Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 11 to 15, 2022. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 11 to 15, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
FDA Approves First Breath Test for COVID-19
FRIDAY, April 15, 2022 (HealthDay News) — People who suspect they may have COVID-19 could soon find out with a simple breath test that delivers results in three minutes.
Psychiatric Disorders May Up SARS-CoV-2 Breakthrough Infection Risk
FRIDAY, April 15, 2022 (HealthDay News) — Fully vaccinated individuals with psychiatric disorders may be at increased risk for severe acute respiratory syndrome coronavirus 2 breakthrough infection, according to a study published online April 14 in JAMA Network Open.
Third mRNA COVID-19 Vaccine Dose Appears to Be Safe
FRIDAY, April 15, 2022 (HealthDay News) — The third dose of the COVID-19 mRNA vaccine is safe, according to a study published online April 14 in JAMA Network Open.
Rate of Retinal Vein Occlusions Up After COVID-19 Infection
FRIDAY, April 15, 2022 (HealthDay News) — The risk for retinal vein occlusion may be increased in the six months following COVID-19 infection, according to a study published online April 14 in JAMA Ophthalmology.
Pfizer Says Its Booster Shot Bolsters Immune Response in Those Aged 5 to 11 Years
THURSDAY, April 14, 2022 (HealthDay News) — Pfizer Inc. said Thursday that its booster shot raised levels of neutralizing antibodies against both the original coronavirus strain and the omicron variant in children aged 5 to 11 years.
Two New Omicron Subvariants Fueling COVID-19 Infections in New York State
THURSDAY, April 14, 2022 (HealthDay News) — Rising COVID-19 infections in New York state appear to be driven by two new versions of the omicron BA.2 variant and may explain why the state has been the national coronavirus hot spot in recent weeks, state health officials said Wednesday.
Biden Administration Extends COVID-19 Public Health Emergency for 90 Days
THURSDAY, April 14, 2022 (HealthDay News) — America’s public health emergency plan for COVID-19 will continue for at least another 90 days, the Biden administration announced Wednesday. Pushing the deadline to mid-July means that vulnerable Americans will keep getting the health care benefits the program offers.
Health Care Personnel More Likely to be Exposed to COVID-19 at Work
THURSDAY, April 14, 2022 (HealthDay News) — Health care personnel with COVID-19 were more likely to be exposed to severe acute respiratory syndrome coronavirus 2 in their workplace than in the community, according to a study published online April 14 in the American Journal of Infection Control.
COVID-19 Cases Reach 500 Million Worldwide
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis 
U.S. Adults May Not Understand Their Risk for Vascular Disease 
Lower Breast, Cervical Cancer Screening Seen for Adults With Disabilities 
Screening + Online Cognitive Behavioral Therapy Program Aids Nurses" Mental Health 
